Cigna Corporation with ticker code (CI) have now 23 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 330 and 230 with the average target price sitting at 285.83. Now with the previous closing price of 259.49 this would imply there is a potential upside of 10.2%. The 50 day MA is 251.26 and the 200 day MA is 226.06. The market capitalisation for the company is $83,560m. Find out more information at: https://www.cigna.com
The potential market cap would be $92,042m based on the market concensus.
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company’s Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
